Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid.
Pablo Muriel, Mario G Moreno, María Del C Hernández, Enrique Chávez, Lidia K Alcantar
文献索引:Basic Clin Pharmacol Toxicol. 96(5) , 375-80, (2005)
全文:HTML全文
摘要
The purpose of this work was to obtain a suitable model of fibrosis, in which spontaneous reversion was minimal, to study the ability of silymarin, silibinin, colchicine and trimethylcolchicinic acid (TMCA) to reverse it. Reversal of liver fibrosis was studied in male Wistar rats after one, two or three months of CCl(4) administration (0.4 g/kg intraperitoneally, three times per week), by discontinuation of the toxin for 2 months. Silymarin (50 mg/kg), silibinin (50 mg/kg), colchicine (10 microg/rat) and trimethylcolchicinic acid (100 microg/rat) were administered daily, by gavage, after 3 months of CCl(4) administration. Collagen content was determined by measuring hydroxyproline in liver samples; glycogen, was determined utilizing the anthrone reagent; Mallory's trichromic stains of liver sections were performed. The best scheme of treatment was obtained when CCl(4) was administered during three months (collagen increased 6 times). Discontinuation of the toxin for two months produced a significant but relative small reduction of fibrosis (collagen was still 4.5 times over control). Colchicine, TMCA, silymarin or silibinin treatment showed no significant fibrolitic effect. This scheme of treatment may be an excellent tool to study the ability of drugs to reverse fibrosis. The hepatoprotective properties of silymarin, silibinin, colchicine and trimethylcolchinic acid may be irrelevant to reverse established cirrhosis.
相关化合物
相关文献:
1996-11-01
[Pharmacol. Toxicol. 79(5) , 241-6, (1996)]
1983-08-01
[Cell Biol. Int. Rep. 7(8) , 593-602, (1983)]
1996-01-01
[J. Appl. Toxicol. 16(3) , 269-75, (1996)]
1997-01-01
[J. Appl. Toxicol. 17(3) , 145-51, (1997)]